Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Pulmonary Pharmacology & Therapeutics|December 25, 2019
Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5Roland Buhl, J M FitzGerald, Eli O Meltzer, et al.
Allergy and Asthma Proceedings|January 29, 2009
The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America surveyRobert A Nathan, Eli O Meltzer, Jennifer Derebery, et al.
Clinical Therapeutics|March 18, 2008
Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover studyEli O Meltzer, Jon E Stahlman, Jeffrey Leflein, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 5, 2005
Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitisEli O Meltzer, James Hadley, Michael Blaiss, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 2, 2016
Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessmentWilliam Berger, Eli O Meltzer, Niran Amar, et al.
Respiratory Medicine|October 27, 2019
Tiotropium Respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristicsThomas B Casale, René Aalbers, Eugene R Bleecker, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 30, 2004
Latino children with asthma: rates and risks for medical care utilizationJill Berg, Dennis R Wahlgren, C Richard Hofstetter, et al.
Allergy and Asthma Proceedings|January 16, 2009
Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%Eli O Meltzer, Rekha Garadi, Craig Laforce, et al.
American Journal of Rhinology|January 13, 2006
Montelukast effectively treats the nighttime impact of seasonal allergic rhinitisEli O Meltzer, George Philip, Steven F Weinstein, et al.
Respiratory Research|July 20, 2019
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1David M G Halpin, Eli O Meltzer, Wendelgard Pisternick-Ruf, et al.
Pageof 15